iBio (IBIO) Return on Equity [ROE] (2009 - 2026)
iBio (IBIO) posted Return on Equity [ROE] of -40.48% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 99.47 percentage points from -139.96% a year earlier and up 0.69 percentage points from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio's Return on Equity [ROE] came in at -65.70%, up 35.82 percentage points from FY2025.
- Annual Return on Equity [ROE] has increased for three consecutive fiscal years, though with a five-year change of -37.59 percentage points (FY2021 to FY2026).
- In prior fiscal years, iBio's Return on Equity [ROE] was -101.52% in FY2025 (+34.20 pp), -135.71% in FY2024 (+29.15 pp), -164.86% in FY2023 (-106.39 pp) and -58.48% in FY2022 (-30.37 pp).
- The fiscal Q4 2026 figure stands as the highest quarterly Return on Equity [ROE] since fiscal Q3 2022.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last four quarters, with an average year-over-year change of +84.16 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q4 2024, with a gain of 288.91 percentage points; the weakest was fiscal Q3 2023, with a drop of 380.93 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -41.17% (Q3 2026), -43.94% (Q2 2026) and -56.71% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | -9,320.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -9,320.93% |
| Jun 30, 2026 | -7,059.55% |
| Mar 31, 2026 | -8,586.16% |
| Dec 31, 2025 | -10,220.33% |
| Sep 30, 2025 | -16,213.96% |
| Jun 30, 2025 | -30,489.23% |
| Mar 31, 2025 | -228,581.23% |
| Dec 31, 2024 | -182,542.30% |
| Sep 30, 2024 | -147,859.43% |
| Jun 30, 2024 | -107,852.86% |
| Mar 31, 2024 | -381,492.38% |
| Dec 31, 2023 | -579,954.24% |
| Sep 30, 2023 | -454,687.76% |
| Jun 30, 2023 | -396,765.33% |
| Mar 31, 2023 | -419.92% |
| Dec 31, 2022 | -241.48% |
| Sep 30, 2022 | -106.38% |
| Jun 30, 2022 | -70.42% |
| Mar 31, 2022 | -38.99% |
| Dec 31, 2021 | -29.73% |
API Access
iBio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();